Scientific Session
Osteoarthritis (OA) and related disorders
C. Thomas Appleton, MD, PhD, FRCPC
The University of Western Ontario
London, ON, Canada
Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Advisor or Review Panel Member (Ongoing); Celgene: Advisor or Review Panel Member (Ongoing); Eli Lilly: Advisor or Review Panel Member (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Advisor or Review Panel Member (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)